MBX Capital
Venture capitalActively deployingTuxedo Park · Seed–Series A · 2 people tracked
Investment thesis
MBX Capital targets early-stage deep health innovations across multiple vectors including therapeutics, diagnostics, digital health, and healthcare infrastructure. The portfolio demonstrates investment in cutting-edge modalities such as synthetic biology, AI-enabled drug discovery, organoid-based testing platforms, novel psychiatric treatments, and precision diagnostics. The firm seeks founders with visionary approaches to solving fundamental healthcare challenges through scientific innovation and technological advancement.
Source: firm website, verified Jul 21, 2026.
Team · 2 people
from the firm's websiteWhat they invest in
from 1 of 26 portfolio companiesAI & Machine Learning ×1Digital Health ×1Enterprise Software ×1Healthtech ×1
Investments · 26 tracked
founders shown can be your intro pathCreating a comprehensive medication management solution.
Atlas Health uses AI-driven patient assistance to help health systems connect patients to financial resources and reduce barriers to care. The platform simplifies healthcare funding complexity to improve access and patient outcomes.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtech
Biomaterial vaccine platform for infectious and chronic diseases.
Protein coupling technology to create better vaccines and medicines for auto-immune diseases.
Improving access to quality dental healthcare throughout India.
Synthetic biomarkers for early detection of cancers.
Engineered receptors to control cell signaling.
Making world-class radiology technology available in LATAM.
Cloud infrastructure for computational chemistry.
Industry-best AI for medical coding.
Making peer support accessible for people navigating life's biggest challenges.
Novel ketamine formulations for treatment resistant depression.
Psychedelic therapies for addiction.
Infusion therapy infrastructure for community health centers.
A new standard of care in IVF preimplantation genetic testing.
AI for chronic disease detection.
Making high value clinical trials faster and more inclusive.
Closing the maternal health gap for minority mothers.
Reducing wait times for surgical procedures for Medicaid members.
AI+robotics for 10x faster drug formulation screening.
Accessible mental healthcare for all case severities.
Green chemistry for pollution abatement in water and agriculture.
Synthetic peptide vaccines for chronic diseases.
Bringing lab testing to point-of-care.
Unlocking the power of organoids-on-a-chip in safety toxicology.
Developing a high-throughput, optimized in vivo testing platform.
Frequently asked questions
- What stage does MBX Capital invest at?
- MBX Capital invests at the Seed, Series A stages.
- What sectors does MBX Capital focus on?
- MBX Capital focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.
- Where is MBX Capital located?
- MBX Capital is headquartered in Tuxedo Park, US.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.